Age-dependent variation of genotypes in MHC II transactivator gene (CIITA) in controls and association to type 1 diabetes

Genes and Immunity

Volumn 13, Issue 8, 2012, Pages 632-640

  Gyllenberg, A ^a   Asad, S ^b   Piehl, F ^a   Swanberg, M ^a   Padyukov, L ^c   Van Yserloo, B ^d   Rutledge, E A ^e   McNeney, B ^f   Graham, J ^f   Orho Melander, M ^g   Lindholm, E ^g   Graff, C ^a,c   Forsell, C ^a,c   Akesson K ^g,h,l   Landin Olsson, M ^g   Carlsson, A ^g   Forsander, G ⁱ   Ivarsson, S A ^g   Larsson, H ^g   Lindblad, B ^j   Ludvigsson, J ^k   Marcus, C ^c   Lernmark, A ^d,g   Alfredsson, L ^c   Olsson, T ^a   Kockum, I ^a   more..

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Salish Kootenai College   (United States)

^f SIMON FRASER UNIVERSITY   (Canada)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h RYHOV COUNTY HOSPITAL   (Sweden)

ⁱ QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^j UNIVERSITY OF GOTHENBURG   (Sweden)

^k LINKÖPING UNIVERSITY   (Sweden)

^l LUND UNIVERSITY   (Sweden)

more..

Author keywords

age; association; autoimmunity; CIITA; type 1 diabetes (T1D)

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SWEDEN;

ADOLESCENT; ADULT; AGE FACTORS; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; LECTINS, C-TYPE; LINKAGE DISEQUILIBRIUM; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN; TRANS-ACTIVATORS;

EID: 84870882497     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2012.44     Document Type: Article

References (49)

1. Todd JA. Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci USA 1995; 92: 8560-8565.
2. Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark A. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur J Immunogenet 1999; 26: 361-372.
3. Graham J, Kockum I, Sanjeevi CB, Landin-Olsson M, Nystrom L, Sundkvist G et al. Negative association between type 1 diabetes and HLA DQB1*0602- DQA1*0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group. Eur J Immunogenet 1999; 26: 117-127.
4. Masternak K, Muhlethaler-Mottet A, Villard J, Zufferey M, Steimle V, Reith W. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev 2000; 14: 1156-1166.
5. Zhou H, Glimcher LH. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 1995; 2: 545-553.
6. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 1994; 265: 106-109.
7. Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli C. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr 1993; 123: 921-928.
8. Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J 1997; 16: 2851-2860.
9. LeibundGut-Landmann S, Waldburger JM, Reis e Sousa C, Acha-Orbea H, Reith W. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat Immunol 2004; 5: 899-908.
10. Sartoris S, Brendolan A, Degola A, Testi MG, Chignola R, Scarpa A et al. Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability. Hum Immunol 2000; 61: 599-604.
11. Nerup J, Pociot F. A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions. Am J Hum Genet 2001; 69: 1301-1313.
12. Caillat-Zucman S, Garchon HJ, Timsit J, Assan R, Boitard C, Djilali-Saiah I et al. Agedependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992; 90: 2242-2250.
13. Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002; 51: 1346-1355.
14. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011; 43: 1193-1201.
15. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005; 37: 486-494.
16. Jensen RA, Gilliam LK, Torn C, Landin-Olsson M, Karlsson FA, Palmer JP et al. Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15-to 35-year-old diabetic subjects. J Diabetes Complications 2007; 21: 205-213.
17. Consortium WTCC. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678.
18. Bronson PG, Caillier S, Ramsay PP, McCauley JL, Zuvich RL, De Jager PL et al. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. Hum Mol Genet 2010; 19: 2331-2340.
19. Iikuni N, Ikari K, Momohara S, Tomatsu T, Hara M, Yamanaka H et al. MHC2TA is associated with rheumatoid arthritis in Japanese patients. Ann Rheum Dis 2007; 66: 274-275.
20. Martinez A, Sanchez-Lopez M, Varade J, Mas A, Martin MC, de Las Heras V et al. Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis 2007; 66: 325-329.
21. Cooper JD, Walker NM, Smyth DJ, Downes K, Healy BC, Todd JA. Follow-up of 1715. SNPs from the Wellcome Trust Case Control Consortium genome-wide association study in type I diabetes families. Genes Immun 2009; 10(Suppl 1): S85-S94.
22. Larsen CE, Alper CA. The genetics of HLA-associated disease. Curr Opin Immunol 2004; 16: 660-667.
23. Eyre S, Bowes J, Spreckley K, Potter C, Ring S, Strachan D et al. Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort. Arthritis Rheum 2006; 54: 3417-3422.
24. Harrison P, Pointon JJ, Farrar C, Harin A, Wordsworth BP. MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients. Rheumatology (Oxford) 2007; 46: 409-411.
25. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857-864.
26. Landin-Olsson M, Karlsson FA, Lernmark A, Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15-to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes 1992; 41: 1022-1027.
27. Dahlquist G, Blom L, Tuvemo T, Nystrom L, Sandstrom A, Wall S. The Swedish childhood diabetes study-results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 1989; 32: 2-6.
28. Carlsson A, Kockum I, Lindblad B, Engleson L, Nilsson A, Forsander G et al. Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden. Int J Obes (Lond) 2012; 36: 718-724.
29. Lindholm E, Agardh E, Tuomi T, Groop L, Agardh CD. Classifying diabetes according to the new WHO clinical stages. Eur J Epidemiol 2001; 17: 983-989.
30. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003; 62: 835-841.
31. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007; 357: 1199-1209.
32. Roos IM, Kockum I, Hillert J. The interleukin 23 receptor gene in multiple sclerosis: a case-control study. J Neuroimmunol 2008; 194: 173-180.
33. Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009; 73: 696-701.
34. Bjork BF, Katzov H, Kehoe P, Fratiglioni L, Winblad B, Prince JA et al. Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE. Neurobiol Aging 2007; 28: 1374-1380.
35. McGuigan FE, Larzenius E, Callreus M, Gerdhem P, Luthman H, Akesson K. Variation in the BMP2 gene: bone mineral density and ultrasound in young adult and elderly women. Calcif Tissue Int 2007; 81: 254-262.
36. Gerdhem P, Isaksson A, Akesson K, Obrant KJ. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 2005; 16: 1506-1512.
37. Ekelund E, Saaf A, Tengvall-Linder M, Melen E, Link J, Barker J et al. Elevated expression and genetic association links the SOCS3 gene to atopic dermatitis. Am J Hum Genet 2006; 78: 1060-1065.
38. Prince JA, Feuk L, Howell WM, Jobs M, Emahazion T, Blennow K et al. Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res 2001; 11: 152-162.
39. Roach JC, Deutsch K, Li S, Siegel AF, Bekris LM, Einhaus DC et al. Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in sweden. Am J Hum Genet 2006; 79: 614-627.
40. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequencespecific primers (PCR-SSP) in 2 h: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigen 1992; 39: 225-235.
41. Kiviniemi M, Hermann R, Nurmi J, Ziegler AG, Knip M, Simell O et al. A highthroughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study. Diabetes Technol Ther 2007; 9: 460-472.
42. Zhang K, Deng M, Chen T, Waterman MS, Sun F. A dynamic programming algorithm for haplotype block partitioning. Proc Natl Acad Sci USA 2002; 99: 7335-7339.
43. Zhang K, Jin L. HaploBlockFinder: haplotype block analyses. Bioinformatics 2003; 19: 1300-1301.
44. Zhang K, Qin ZS, Liu JS, Chen T, Waterman MS, Sun F. Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies. Genome Res 2004; 14: 908-916.
45. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005; 20: 575-579.
46. Knol MJ, VanderWeele TJ. Recoding preventive exposures to get valid measures of interaction on an additive scale. Eur J Epidemiol 2011; 26: 825-826.
47. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2008.
48. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008; 66: 87-98.
49. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.